SEMAGLUTIDE AND TIRZEPATIDE IN TYPE 2 DIABETES: PATIENT CHARACTERISTICS AND WEIGHT-RELATED OUTCOMES IN THE REAL-WORLD SETTING

被引：0
|
作者：
Althoff, A. [1 ]
Rasouliyan, L. [1 ]
机构：
[1] OMNY Hlth, Atlanta, GA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD104
引用
收藏
页码：S238 / S239
页数：2
相关论文
共 50 条
  • [11] Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting
    Buysman, Erin K.
    Chow, Wing
    Henk, Henry J.
    Rupnow, Marcia F. T.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) : 137 - 143
  • [12] Oral versus subcutaneous semaglutide weight loss outcomes after two years among patients with type 2 diabetes in a real-world database
    Kwon, Jimmy
    Thiara, Diana
    Watanabe, Jonathan H.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2025, 20 (02) : 163 - 168
  • [13] How Effective Is Weight Loss by Oral Semaglutide on Glycemic Control in a Real-World Setting?
    Kesavadev, Jothydev
    Shankar, Arun
    Joshi, Shashank R.
    Ashik, Asha
    Yasmin, Shahana
    Basanth, Anjana
    Raj, Sourav K.
    Jothydev, Sunitha
    DIABETES, 2024, 73
  • [14] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Alabduljabbar, Khaled
    Alsaqaaby, Moath
    Neff, Karl J.
    Crotty, Michael
    le Roux, Carel W.
    ENDOCRINE, 2024, 83 (02) : 392 - 398
  • [15] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Khaled Alabduljabbar
    Moath Alsaqaaby
    Karl J. Neff
    Michael Crotty
    Carel W. le Roux
    Endocrine, 2024, 83 : 392 - 398
  • [16] Real-World Use of Once-Weekly Semaglutide in Thai Patients With Type 2 Diabetes Mellitus in a Private Hospital Setting
    Thewjitcharoen, Yotsapon
    Yenseung, Nalin
    Butadej, Siriwan
    Nakasatien, Soontaree
    Chotwanvirat, Phawinpon
    Chatchomchuan, Waralee
    Wanothayaroj, Ekgaluck
    Krittiyawong, Sirinate
    Himathongkam, Thep
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (01): : 21 - 28
  • [17] Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies
    Rudofsky, Gottfried
    Amadid, Hanan
    Braae, Uffe Christian
    Catrina, Sergiu-Bogdan
    Kick, Anastas
    Mandavya, Kabirdev
    Roslind, Klaus
    Saravanan, Ponnusamy
    van Houtum, William
    Jain, Akshay B.
    DIABETES THERAPY, 2025, 16 (01) : 73 - 87
  • [18] Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence
    Singh, Awadhesh Kumar
    Singh, Ritu
    Singh, Akriti
    Misra, Anoop
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (05)
  • [19] A district general hospital real-world experience of the use of semaglutide in patients with type 2 diabetes
    Liarakos, A. L.
    Smith, L.
    Patel, K.
    Mani, H.
    Pierides, M.
    DIABETIC MEDICINE, 2020, 37 : 131 - 131
  • [20] Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
    Buysman, Erin K.
    Chow, Wing
    Henk, Henry J.
    Rupnow, Marcia F. T.
    BMC ENDOCRINE DISORDERS, 2015, 15
12345